Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

ConclusionOverall, lemborexant at recommended doses did not have a negative effect on mean SpO2 or AHI and was well tolerated in this cohort of healthy subjects.

Source: Clinical Drug Investigation - March 16, 2021 Category: Drugs & Pharmacology Source Type: research